The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
Open accessAbstract
Over 150 mutations within the coding sequence of the V2 vasopressin receptor (V2R) gene are known to cause nephrogenic diabetes insipidus (NDI). A large number of these mutant receptors fail to fold properly and therefore are not routed to the cell surface. Here we show that selective, nonpeptidic V2R antagonists dramatically increase cell-surface expression and rescue the function of 8 mutant NDI-V2Rs by promoting their proper folding and maturation. A cell-impermeant V2R antagonist could not mimic these effects and was unable to block the rescue mediated by a permeant agent, indicating that the nonpeptidic antagonists act intracellularly, presumably by binding to and stabilizing partially folded mutants. In addition to opening new therapeutic avenues for NDI patients, these data demonstrate that by binding to newly synthesized mutant receptors, small ligands can act as pharmacological chaperones, promoting the proper folding and maturation of receptors and their targeting to the cell surface.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSEMBLY OF ASPARAGINE-LINKED OLIGOSACCHARIDES
Kornfeld, R., & Kornfeld, S. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.003215 · Cited by 4,906
Cheng, S. H., Gregory, R. J., Marshall, J., Paul, S., Souza, D. W., White, G. A., O'Riordan, C. R., & Smith, A. E. (1990) · Cell · doi:10.1016/0092-8674(90)90148-8 · Cited by 1,792
[71] Use of eukaryotic expression technology in the functional analysis of cloned genes
Cullen, B. R. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)52074-2 · Cited by 822
Binding of a specific ligand inhibits import of a purified precursor protein into mitochondria
Eilers, M., & Schatz, G. (1986) · Nature · doi:10.1038/322228a0 · Cited by 720
Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation
Dalemans, W., Barbry, P., Champigny, G., Jallat, S., Jallat, S., Dott, K., Dreyer, D., Crystal, R. G., Pavirani, A., Lecocq, J.-P., et al. (1991) · Nature · doi:10.1038/354526a0 · Cited by 707
Chloride Conductance Expressed by ΔF508 and Other Mutant CFTRs In Xenopus Oocytes
Drumm, M. L., Wilkinson, D. J., Smit, L. S., Worrell, R. T., Strong, T. V., Frizzell, R. A., Dawson, D. C., & Collins, F. S. (1991) · Science · doi:10.1126/science.1722350 · Cited by 496
Influence of molecular and chemical chaperones on protein folding
Welch, W. J., & Brown, C. R. (1996) · Cell Stress & Chaperones · doi:10.1379/1466-1268(1996)001<0109:iomacc>2.3.co;2 · Cited by 495
Tamarappoo, B. K., & Verkman, A. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2303 · Cited by 329
Structural Instability of a Constitutively Active G Protein-coupled Receptor
Gether, U., Seifert, R., Ballesteros, J. A., Sanders-Bush, E., Weinstein, H., & Kobilka, B. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2587 · Cited by 295
Lehrman, M. A., Schneider, W. J., Brown, M. S., Davis, C. G., Elhammer, A., Russell, D. W., & Goldstein, J. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75941-9 · Cited by 282
Jard, S., Gaillard, R. C., Guillon, G., Marie, J., Schoenenberg, P., Muller, A. F., Manning, M., & Sawyer, W. H. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10336-2 · Cited by 276
Serradeil-Le Gal, C., Lacour, C., Valette, G., Garcia, G., Foulon, L., Galindo, G., Bankir, L., Pouzet, B., Guillon, G., Barberis, C., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119098 · Cited by 250
Smit, M. J., Leurs, R., Alewijnse, A. E., Blauw, J., Van Nieuw Amerongen, G. P., Van De Vrede, Y., Roovers, E., & Timmerman, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6802 · Cited by 242
Mutant α subunits of Gi2 inhibit cyclic AMP accumulation
Wong, Y. H., Federman, A., Pace, A. M., Zachary, I., Evans, T., Pouysségur, J., & Bourne, H. R. (1991) · Nature · doi:10.1038/351063a0 · Cited by 235
Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators
Loo, T. W., & Clarke, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.709 · Cited by 224
Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport
Gow, A., Friedrich, V. L., & Lazzarini, R. A. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370504 · Cited by 159
Schöneberg, T., Yun, J., Wenkert, D., & Wess, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00470.x · Cited by 151
Albright, J. D., Reich, M. F., Santos, E. G. D., Dusza, J. P., Sum, F., Venkatesan, A. M., Coupet, J., Chan, P. S., Ru, X., Mazandarani, H., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980179c · Cited by 151
Hou, W.-S., Brömme, D., Zhao, Y., Mehler, E. L., Dushey, C., Weinstein, H., Sá-Miranda, C., Fraga, C., Greig, F., Carey, J. C., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci653 · Cited by 149
The molecular basis of nephrogenic diabetes insipidus
Oksche, A., & Rosenthal, W. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050224 · Cited by 137
Ala, Y., Morin, D., Mouillac, B., Sabatier, N., Vargas‐Poussou, R., de la Cotte, N., Déchaux, M., Antignac, C., Arthus, M., Lonergan, M., et al. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9101861 · Cited by 111
Self-citationOksche, A., Schülein, R., Rutz, C., Liebenhoff, U., Dickson, J., Müller, H., Birnbaumer, M. E., & Rosenthal, W. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09382-4 · Cited by 90
Morin, D., de la Cotte, N., Balestre, M., Mouillac, B., Manning, M., Breton, C., & Barberis, C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01585-3 · Cited by 89
Self-citationSingh, N., Zanusso, G., Chen, S. G., Fujioka, H., Richardson, S., Gambetti, P. L., & Petersen, R. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28461 · Cited by 89
Functional characterization of five V2 vasopressin receptor gene mutations
Wenkert, D., Schöneberg, T., Merendino, J. J., Rodríguez-Peña, M. S., Vinitsky, R., Goldsmith, P. K., Wess, J., & Spiegel, A. M. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(96)03926-3 · Cited by 70
Schöneberg, T., Sandig, V., Wess, J., Gudermann, T. W., & Schultz, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119678 · Cited by 66
O-Glycosylation of the V2 vasopressin receptor
Sadeghi, H. M. (1999) · Glycobiology · doi:10.1093/glycob/9.7.731 · Cited by 61
Membrane Targeting and Determination of Transmembrane Topology of the Human Vasopressin V2 Receptor
Schülein, R., Rutz, C., & Rosenthal, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28844 · Cited by 45
Nephrogenic Diabetes Insipidus
Knoers, N. V. A. M., & Monnens, L. (2012) · SpringerReference · doi:10.1007/springerreference_167647 · Cited by 23
6-Aminohexanoic Acid as a Chemical Chaperone for Apolipoprotein(a)
Wang, J., & White, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12883 · Cited by 21
Cited by
Quality control in the endoplasmic reticulum
Ellgaard, L., & Helenius, A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1052 · Cited by 2,126
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
Kim, I., Xu, W., & Reed, J. C. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2755 · Cited by 1,817
Therapeutic approaches to protein-misfolding diseases
Cohen, F. E., & Kelly, J. W. (2003) · Nature · doi:10.1038/nature02265 · Cited by 800
In and Out of the ER: Protein Folding, Quality Control, Degradation, and Related Human Diseases
Hebert, D. N., & Molinari, M. (2007) · Physiological Reviews · doi:10.1152/physrev.00050.2006 · Cited by 671
Oligomerization of G-protein-coupled transmitter receptors
Bouvier, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067575 · Cited by 669
Self-citation
Metadata
- Authors
- Morello, J.-P., Salahpour, A., Laperrière, A., Bernier, V., Arthus, M.-F., Lonergan, M., Petäjä-Repo, U., Angers, S., Morin, D., Bichet, D. G., & Bouvier, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-04-01
- Volume
- 105
- Issue
- 7
- Pages
- 887-895
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2157907012
- Cited by
- 565
- References
- 30
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.